HEALTH● LOW2h ago · Nov 2, 2026, 4:00 PM
US approves economic version of HIV preventive treatment
Clarín · global
The FDA approved a generic injectable HIV preventive, facilitating its access in low-income countries. This advance reduces the risk of transmission by 99.9%. The treatment, at 40 dollars annually, will be available in 120 nations, thanks to an agreement between Dr. Reddy's, Unitaid, and other entities.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH37m agoRecent virus outbreaks show urgent need to complete pandemic treaty, says WHO chiefEuroNews [en]HEALTH39m agoData reveals that Americans who vote live longer than those who don’tThe Independent WorldHEALTH57m agoFor years she suffered abdominal pains and they discovered she was carrying a stone baby in her wombClarínHEALTHBREAKING1h agoEbola kills over 5,300 in fastest-growing outbreak on recordEuroNews [en]